Literature DB >> 19865792

Parenchyma-sparing resections for pancreatic neoplasms.

Stefano Crippa1, Letizia Boninsegna, Stefano Partelli, Massimo Falconi.   

Abstract

BACKGROUND/
PURPOSE: In recent years there has been an increase in the indications for pancreatic resection of benign or low-grade malignant lesions, especially in young patients with long life expectancy. In this setting, patients may benefit from parenchyma-sparing resections in order to decrease the risk of development of exocrine/endocrine insufficiency.
METHODS: A review of the literature and authors experience was undertaken.
RESULTS: Parenchyma-sparing resections of the pancreas including enucleation, middle pancreatectomy (MP) and middle-preserving pancreatectomy are described. Short and long-term outcomes after surgery are analyzed with special regard to postoperative morbidity/mortality, and oncological and functional long-term results.
CONCLUSIONS: Parenchyma-sparing resections are safe and effective procedures for treatment of benign and low-grade malignant neoplasms. Despite a significant postoperative morbidity they are associated with good long-term functional and oncological results. Enucleation should preferentially be performed laparoscopically whenever possible.

Entities:  

Mesh:

Year:  2009        PMID: 19865792     DOI: 10.1007/s00534-009-0224-1

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  23 in total

1.  Laparoscopic versus open enucleation for pancreatic neoplasms: clinical outcomes and pancreatic function analysis.

Authors:  Ren-Chao Zhang; Yu-Cheng Zhou; Yi-Ping Mou; Chao-Jie Huang; Wei-Wei Jin; Jia-Fei Yan; Yong-Xiang Wang; Yi Liao
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

2.  Few Comments on "Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors".

Authors:  Haoyuan Ren; Xubao Liu
Journal:  J Gastrointest Surg       Date:  2019-12-03       Impact factor: 3.452

3.  Pancreatic Neuroendocrine Tumors: an Update.

Authors:  Alessandro Paniccia; Barish H Edil; Richard D Schulick
Journal:  Indian J Surg       Date:  2015-10-13       Impact factor: 0.656

Review 4.  Laparoscopic surgery for pancreatic lesions: current status and future.

Authors:  Taiping Zhang; Xiao Du; Yupei Zhao
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

5.  Pancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesions.

Authors:  Jasper Jan Atema; Anneke P J Jilesen; Olivier R C Busch; Thomas M van Gulik; Dirk J Gouma; Els J M Nieveen van Dijkum
Journal:  HPB (Oxford)       Date:  2014-07-18       Impact factor: 3.647

Review 6.  Minimally invasive surgical approach to pancreatic malignancies.

Authors:  Lapo Bencini; Mario Annecchiarico; Marco Farsi; Ilenia Bartolini; Vita Mirasolo; Francesco Guerra; Andrea Coratti
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

7.  Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors.

Authors:  Kristin Heeger; Massimo Falconi; Stefano Partelli; Jens Waldmann; Stefano Crippa; Volker Fendrich; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2014-02-14       Impact factor: 3.445

Review 8.  Update on pancreatic neuroendocrine tumors.

Authors:  Logan R McKenna; Barish H Edil
Journal:  Gland Surg       Date:  2014-11

9.  Parenchyma-sparing resections for pancreatic neuroendocrine tumors.

Authors:  Rim Cherif; Sébastien Gaujoux; Anne Couvelard; Safi Dokmak; Marie-Pierre Vuillerme; Philippe Ruszniewski; Jacques Belghiti; Alain Sauvanet
Journal:  J Gastrointest Surg       Date:  2012-08-22       Impact factor: 3.452

Review 10.  Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.

Authors:  Sébastien Gaujoux; Alain Sauvanet; Jacques Belghiti
Journal:  Target Oncol       Date:  2012-08-25       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.